Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mathurin Dorel

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Biochemical and Biophysical Research Communications|June 19, 2015
Network-based approaches for drug response prediction and targeted therapy development in cancerMathurin Dorel, Emmanuel Barillot, Andrei Zinovyev, et al.
Database : the Journal of Biological Databases and Curation|April 18, 2017
NaviCom: a web application to create interactive molecular network portraits using multi-level omics dataMathurin Dorel, Eric Viara, Emmanuel Barillot, et al.
Molecular Systems Biology|September 22, 2023
Modeling unveils sex differences of signaling networks in mouse embryonic stem cellsZeba Sultana, Mathurin Dorel, Bertram Klinger, et al.
Bioinformatics (Oxford, England)|June 23, 2018
Modelling signalling networks from perturbation dataMathurin Dorel, Bertram Klinger, Torsten Gross, et al.
Cancer Medicine|January 10, 2025
Inhibiting H3K27 Demethylases Downregulates CREB-CREBBP, Overcoming Resistance in Relapsed Acute Lymphoblastic LeukemiaJuan Lazaro-Navarro, Clara Alcon, Mathurin Dorel, et al.
Molecular Biology of the Cell|February 21, 2019
Isoform-specific Ras signaling is growth factor dependentFiona E Hood, Bertram Klinger, Anna U Newlaczyl, et al.
Cancer Research|April 7, 2017
Drug Resistance Mechanisms in Colorectal Cancer Dissected with Cell Type-Specific Dynamic Logic ModelsFederica Eduati, Victoria Doldàn-Martelli, Bertram Klinger, et al.
Journal of Experimental & Clinical Cancer Research : CR|September 19, 2025
Mechanistic models position ceritinib as a nuclear integrity disrupting therapy in pediatric liver tumorsSalih Demir, Thomas Kessler, Alina Hotes, et al.
Plos Computational Biology|November 4, 2021
Neuroblastoma signalling models unveil combination therapies targeting feedback-mediated resistanceMathurin Dorel, Bertram Klinger, Tommaso Mari, et al.
Molecular Cancer|June 10, 2022
Mutations in ALK signaling pathways conferring resistance to ALK inhibitor treatment lead to collateral vulnerabilities in neuroblastoma cellsMareike Berlak, Elizabeth Tucker, Mathurin Dorel, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Biochemical and Biophysical Research Communications|June 19, 2015
Network-based approaches for drug response prediction and targeted therapy development in cancerMathurin Dorel, Emmanuel Barillot, Andrei Zinovyev, et al.
Database : the Journal of Biological Databases and Curation|April 18, 2017
NaviCom: a web application to create interactive molecular network portraits using multi-level omics dataMathurin Dorel, Eric Viara, Emmanuel Barillot, et al.
Molecular Systems Biology|September 22, 2023
Modeling unveils sex differences of signaling networks in mouse embryonic stem cellsZeba Sultana, Mathurin Dorel, Bertram Klinger, et al.
Bioinformatics (Oxford, England)|June 23, 2018
Modelling signalling networks from perturbation dataMathurin Dorel, Bertram Klinger, Torsten Gross, et al.
Cancer Medicine|January 10, 2025
Inhibiting H3K27 Demethylases Downregulates CREB-CREBBP, Overcoming Resistance in Relapsed Acute Lymphoblastic LeukemiaJuan Lazaro-Navarro, Clara Alcon, Mathurin Dorel, et al.
Molecular Biology of the Cell|February 21, 2019
Isoform-specific Ras signaling is growth factor dependentFiona E Hood, Bertram Klinger, Anna U Newlaczyl, et al.
Cancer Research|April 7, 2017
Drug Resistance Mechanisms in Colorectal Cancer Dissected with Cell Type-Specific Dynamic Logic ModelsFederica Eduati, Victoria Doldàn-Martelli, Bertram Klinger, et al.
Journal of Experimental & Clinical Cancer Research : CR|September 19, 2025
Mechanistic models position ceritinib as a nuclear integrity disrupting therapy in pediatric liver tumorsSalih Demir, Thomas Kessler, Alina Hotes, et al.
Plos Computational Biology|November 4, 2021
Neuroblastoma signalling models unveil combination therapies targeting feedback-mediated resistanceMathurin Dorel, Bertram Klinger, Tommaso Mari, et al.
Molecular Cancer|June 10, 2022
Mutations in ALK signaling pathways conferring resistance to ALK inhibitor treatment lead to collateral vulnerabilities in neuroblastoma cellsMareike Berlak, Elizabeth Tucker, Mathurin Dorel, et al.
Pageof 1